Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators

Background and Aim Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack. Methods A total of 1097 UGIB attacks in 690 patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology and hepatology 2019-09, Vol.34 (9), p.1604-1610
Hauptverfasser: Fouad, Tamer R, Abdelsameea, Eman, Abdel‐Razek, Wael, Attia, Ahmed, Mohamed, Anwar, Metwally, Khaled, Naguib, Mary, Waked, Imam
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1610
container_issue 9
container_start_page 1604
container_title Journal of gastroenterology and hepatology
container_volume 34
creator Fouad, Tamer R
Abdelsameea, Eman
Abdel‐Razek, Wael
Attia, Ahmed
Mohamed, Anwar
Metwally, Khaled
Naguib, Mary
Waked, Imam
description Background and Aim Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack. Methods A total of 1097 UGIB attacks in 690 patients with liver cirrhosis were studied. Their clinical, laboratory, and endoscopic data were reviewed. Results Mean age 53.2 ± 10.6 (20–90) years, 78% men and the main cause of liver disease was hepatitis C (94.9%). Complications occurred after 467 attacks (42.6%): hepatic encephalopathy 31.4%, spontaneous bacterial peritonitis 18%, renal impairment 13.2%, and re‐bleeding in 7.8%, while 199 patients (18.1%) died. Complications followed 78.4% of bleeding from gastric varices, 75% of post‐interventional ulcers, 10.8% of peptic ulcers, and 5.9% of telangiectasias. By univariate analysis: packed red blood cells units transfused, transaminases, Child–Pugh (CP), model of end‐stage liver disease (MELD), and albumin–bilirubin (ALBI) scores, beside the presence of hepatocellular carcinoma (HCC), previous hemorrhage in the previous 6 months, and the source of bleeding, were associated with occurrence of complications. By multivariate analysis, independent predictors of complications were CP, MELD, and ALBI scores (odds ratio, 95% confidence interval: 5.63, 3.55–8.93; 1.15, 1.11–1.19; and 2.11, 1.4–3.19, respectively) beside the presence of HCC (4.89, 2.48–9.64). Mortality predictors were packed red blood cells units transfused (1.11, 1.01–1.24), CP (5.1, 1.42–18.25) MELD (1.27, 1.21–1.32) scores, and presence of HCC (6.62, 2.93–14.95). Conclusion High CP, MELD, and ALBI scores beside the presence of HCC could predict poor outcome of UGIB. In the absence of these risk factors, early discharge could be considered if the source of bleeding is peptic ulcer or telangiectasia.
doi_str_mv 10.1111/jgh.14659
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2202196487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2202196487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3259-1ae3a3760049aac8532045453b9f0856466d06021b3308f9fcba9f8174ef9acb3</originalsourceid><addsrcrecordid>eNp1kM9OxCAQh4nR6Prn4AsYjnroLhRoizdj1NWY6ME9N5TSFtNCBRqzNx_BZ_RJRFe9OZdJJt_8MvMBcIzRHMdaPLfdHNOM8S0ww5SiBOc02wYzVGCWcIL5Htj3_hkhRFHOdsEeQZzknLMZWK_GUTnYCh-c1SYoH7QRPax6pWptWqgNvGrXY9DCwFEErUzw8FWHDkrtXGe99ufw0frw8fYeOuXEqKagJbRTkHZQUJgajs62JiJxrE2tpQjW-UOw04jeq6OffgBW11dPl8vk_uHm9vLiPpEkZTzBQhFB8izezoWQBSMpoowyUvEGFSyjWVajDKW4IgQVDW9kJXhTRAOq4UJW5ACcbnLjFS9T_K8ctJeq74VRdvJlmsZlntEij-jZBpXOeu9UU45OD8KtS4zKL9NlNF1-m47syU_sVA2q_iN_1UZgsQFeda_W_yeVdzfLTeQnq3iLRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2202196487</pqid></control><display><type>article</type><title>Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Fouad, Tamer R ; Abdelsameea, Eman ; Abdel‐Razek, Wael ; Attia, Ahmed ; Mohamed, Anwar ; Metwally, Khaled ; Naguib, Mary ; Waked, Imam</creator><creatorcontrib>Fouad, Tamer R ; Abdelsameea, Eman ; Abdel‐Razek, Wael ; Attia, Ahmed ; Mohamed, Anwar ; Metwally, Khaled ; Naguib, Mary ; Waked, Imam</creatorcontrib><description>Background and Aim Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack. Methods A total of 1097 UGIB attacks in 690 patients with liver cirrhosis were studied. Their clinical, laboratory, and endoscopic data were reviewed. Results Mean age 53.2 ± 10.6 (20–90) years, 78% men and the main cause of liver disease was hepatitis C (94.9%). Complications occurred after 467 attacks (42.6%): hepatic encephalopathy 31.4%, spontaneous bacterial peritonitis 18%, renal impairment 13.2%, and re‐bleeding in 7.8%, while 199 patients (18.1%) died. Complications followed 78.4% of bleeding from gastric varices, 75% of post‐interventional ulcers, 10.8% of peptic ulcers, and 5.9% of telangiectasias. By univariate analysis: packed red blood cells units transfused, transaminases, Child–Pugh (CP), model of end‐stage liver disease (MELD), and albumin–bilirubin (ALBI) scores, beside the presence of hepatocellular carcinoma (HCC), previous hemorrhage in the previous 6 months, and the source of bleeding, were associated with occurrence of complications. By multivariate analysis, independent predictors of complications were CP, MELD, and ALBI scores (odds ratio, 95% confidence interval: 5.63, 3.55–8.93; 1.15, 1.11–1.19; and 2.11, 1.4–3.19, respectively) beside the presence of HCC (4.89, 2.48–9.64). Mortality predictors were packed red blood cells units transfused (1.11, 1.01–1.24), CP (5.1, 1.42–18.25) MELD (1.27, 1.21–1.32) scores, and presence of HCC (6.62, 2.93–14.95). Conclusion High CP, MELD, and ALBI scores beside the presence of HCC could predict poor outcome of UGIB. In the absence of these risk factors, early discharge could be considered if the source of bleeding is peptic ulcer or telangiectasia.</description><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1111/jgh.14659</identifier><identifier>PMID: 30937995</identifier><language>eng</language><publisher>Australia</publisher><subject>Adult ; Aged ; Aged, 80 and over ; ALBI score ; cirrhosis ; Disease Progression ; Egypt - epidemiology ; Esophageal and Gastric Varices - diagnosis ; Esophageal and Gastric Varices - epidemiology ; Esophageal and Gastric Varices - mortality ; Esophageal and Gastric Varices - therapy ; Female ; Gastrointestinal Hemorrhage - diagnosis ; Gastrointestinal Hemorrhage - epidemiology ; Gastrointestinal Hemorrhage - mortality ; Gastrointestinal Hemorrhage - therapy ; Hemostatic Techniques ; Humans ; Hypertension, Portal - diagnosis ; Hypertension, Portal - epidemiology ; Hypertension, Portal - mortality ; Hypertension, Portal - therapy ; Length of Stay ; Liver Cirrhosis - diagnosis ; Liver Cirrhosis - epidemiology ; Liver Cirrhosis - mortality ; Liver Cirrhosis - therapy ; Male ; MELD ; Middle Aged ; Patient Discharge ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome ; upper gastrointestinal bleeding ; Young Adult</subject><ispartof>Journal of gastroenterology and hepatology, 2019-09, Vol.34 (9), p.1604-1610</ispartof><rights>2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley &amp; Sons Australia, Ltd</rights><rights>2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley &amp; Sons Australia, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3259-1ae3a3760049aac8532045453b9f0856466d06021b3308f9fcba9f8174ef9acb3</citedby><cites>FETCH-LOGICAL-c3259-1ae3a3760049aac8532045453b9f0856466d06021b3308f9fcba9f8174ef9acb3</cites><orcidid>0000-0002-1542-0265 ; 0000-0003-1286-7616</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjgh.14659$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjgh.14659$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30937995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fouad, Tamer R</creatorcontrib><creatorcontrib>Abdelsameea, Eman</creatorcontrib><creatorcontrib>Abdel‐Razek, Wael</creatorcontrib><creatorcontrib>Attia, Ahmed</creatorcontrib><creatorcontrib>Mohamed, Anwar</creatorcontrib><creatorcontrib>Metwally, Khaled</creatorcontrib><creatorcontrib>Naguib, Mary</creatorcontrib><creatorcontrib>Waked, Imam</creatorcontrib><title>Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators</title><title>Journal of gastroenterology and hepatology</title><addtitle>J Gastroenterol Hepatol</addtitle><description>Background and Aim Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack. Methods A total of 1097 UGIB attacks in 690 patients with liver cirrhosis were studied. Their clinical, laboratory, and endoscopic data were reviewed. Results Mean age 53.2 ± 10.6 (20–90) years, 78% men and the main cause of liver disease was hepatitis C (94.9%). Complications occurred after 467 attacks (42.6%): hepatic encephalopathy 31.4%, spontaneous bacterial peritonitis 18%, renal impairment 13.2%, and re‐bleeding in 7.8%, while 199 patients (18.1%) died. Complications followed 78.4% of bleeding from gastric varices, 75% of post‐interventional ulcers, 10.8% of peptic ulcers, and 5.9% of telangiectasias. By univariate analysis: packed red blood cells units transfused, transaminases, Child–Pugh (CP), model of end‐stage liver disease (MELD), and albumin–bilirubin (ALBI) scores, beside the presence of hepatocellular carcinoma (HCC), previous hemorrhage in the previous 6 months, and the source of bleeding, were associated with occurrence of complications. By multivariate analysis, independent predictors of complications were CP, MELD, and ALBI scores (odds ratio, 95% confidence interval: 5.63, 3.55–8.93; 1.15, 1.11–1.19; and 2.11, 1.4–3.19, respectively) beside the presence of HCC (4.89, 2.48–9.64). Mortality predictors were packed red blood cells units transfused (1.11, 1.01–1.24), CP (5.1, 1.42–18.25) MELD (1.27, 1.21–1.32) scores, and presence of HCC (6.62, 2.93–14.95). Conclusion High CP, MELD, and ALBI scores beside the presence of HCC could predict poor outcome of UGIB. In the absence of these risk factors, early discharge could be considered if the source of bleeding is peptic ulcer or telangiectasia.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>ALBI score</subject><subject>cirrhosis</subject><subject>Disease Progression</subject><subject>Egypt - epidemiology</subject><subject>Esophageal and Gastric Varices - diagnosis</subject><subject>Esophageal and Gastric Varices - epidemiology</subject><subject>Esophageal and Gastric Varices - mortality</subject><subject>Esophageal and Gastric Varices - therapy</subject><subject>Female</subject><subject>Gastrointestinal Hemorrhage - diagnosis</subject><subject>Gastrointestinal Hemorrhage - epidemiology</subject><subject>Gastrointestinal Hemorrhage - mortality</subject><subject>Gastrointestinal Hemorrhage - therapy</subject><subject>Hemostatic Techniques</subject><subject>Humans</subject><subject>Hypertension, Portal - diagnosis</subject><subject>Hypertension, Portal - epidemiology</subject><subject>Hypertension, Portal - mortality</subject><subject>Hypertension, Portal - therapy</subject><subject>Length of Stay</subject><subject>Liver Cirrhosis - diagnosis</subject><subject>Liver Cirrhosis - epidemiology</subject><subject>Liver Cirrhosis - mortality</subject><subject>Liver Cirrhosis - therapy</subject><subject>Male</subject><subject>MELD</subject><subject>Middle Aged</subject><subject>Patient Discharge</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>upper gastrointestinal bleeding</subject><subject>Young Adult</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9OxCAQh4nR6Prn4AsYjnroLhRoizdj1NWY6ME9N5TSFtNCBRqzNx_BZ_RJRFe9OZdJJt_8MvMBcIzRHMdaPLfdHNOM8S0ww5SiBOc02wYzVGCWcIL5Htj3_hkhRFHOdsEeQZzknLMZWK_GUTnYCh-c1SYoH7QRPax6pWptWqgNvGrXY9DCwFEErUzw8FWHDkrtXGe99ufw0frw8fYeOuXEqKagJbRTkHZQUJgajs62JiJxrE2tpQjW-UOw04jeq6OffgBW11dPl8vk_uHm9vLiPpEkZTzBQhFB8izezoWQBSMpoowyUvEGFSyjWVajDKW4IgQVDW9kJXhTRAOq4UJW5ACcbnLjFS9T_K8ctJeq74VRdvJlmsZlntEij-jZBpXOeu9UU45OD8KtS4zKL9NlNF1-m47syU_sVA2q_iN_1UZgsQFeda_W_yeVdzfLTeQnq3iLRA</recordid><startdate>201909</startdate><enddate>201909</enddate><creator>Fouad, Tamer R</creator><creator>Abdelsameea, Eman</creator><creator>Abdel‐Razek, Wael</creator><creator>Attia, Ahmed</creator><creator>Mohamed, Anwar</creator><creator>Metwally, Khaled</creator><creator>Naguib, Mary</creator><creator>Waked, Imam</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1542-0265</orcidid><orcidid>https://orcid.org/0000-0003-1286-7616</orcidid></search><sort><creationdate>201909</creationdate><title>Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators</title><author>Fouad, Tamer R ; Abdelsameea, Eman ; Abdel‐Razek, Wael ; Attia, Ahmed ; Mohamed, Anwar ; Metwally, Khaled ; Naguib, Mary ; Waked, Imam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3259-1ae3a3760049aac8532045453b9f0856466d06021b3308f9fcba9f8174ef9acb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>ALBI score</topic><topic>cirrhosis</topic><topic>Disease Progression</topic><topic>Egypt - epidemiology</topic><topic>Esophageal and Gastric Varices - diagnosis</topic><topic>Esophageal and Gastric Varices - epidemiology</topic><topic>Esophageal and Gastric Varices - mortality</topic><topic>Esophageal and Gastric Varices - therapy</topic><topic>Female</topic><topic>Gastrointestinal Hemorrhage - diagnosis</topic><topic>Gastrointestinal Hemorrhage - epidemiology</topic><topic>Gastrointestinal Hemorrhage - mortality</topic><topic>Gastrointestinal Hemorrhage - therapy</topic><topic>Hemostatic Techniques</topic><topic>Humans</topic><topic>Hypertension, Portal - diagnosis</topic><topic>Hypertension, Portal - epidemiology</topic><topic>Hypertension, Portal - mortality</topic><topic>Hypertension, Portal - therapy</topic><topic>Length of Stay</topic><topic>Liver Cirrhosis - diagnosis</topic><topic>Liver Cirrhosis - epidemiology</topic><topic>Liver Cirrhosis - mortality</topic><topic>Liver Cirrhosis - therapy</topic><topic>Male</topic><topic>MELD</topic><topic>Middle Aged</topic><topic>Patient Discharge</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>upper gastrointestinal bleeding</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fouad, Tamer R</creatorcontrib><creatorcontrib>Abdelsameea, Eman</creatorcontrib><creatorcontrib>Abdel‐Razek, Wael</creatorcontrib><creatorcontrib>Attia, Ahmed</creatorcontrib><creatorcontrib>Mohamed, Anwar</creatorcontrib><creatorcontrib>Metwally, Khaled</creatorcontrib><creatorcontrib>Naguib, Mary</creatorcontrib><creatorcontrib>Waked, Imam</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fouad, Tamer R</au><au>Abdelsameea, Eman</au><au>Abdel‐Razek, Wael</au><au>Attia, Ahmed</au><au>Mohamed, Anwar</au><au>Metwally, Khaled</au><au>Naguib, Mary</au><au>Waked, Imam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2019-09</date><risdate>2019</risdate><volume>34</volume><issue>9</issue><spage>1604</spage><epage>1610</epage><pages>1604-1610</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><abstract>Background and Aim Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack. Methods A total of 1097 UGIB attacks in 690 patients with liver cirrhosis were studied. Their clinical, laboratory, and endoscopic data were reviewed. Results Mean age 53.2 ± 10.6 (20–90) years, 78% men and the main cause of liver disease was hepatitis C (94.9%). Complications occurred after 467 attacks (42.6%): hepatic encephalopathy 31.4%, spontaneous bacterial peritonitis 18%, renal impairment 13.2%, and re‐bleeding in 7.8%, while 199 patients (18.1%) died. Complications followed 78.4% of bleeding from gastric varices, 75% of post‐interventional ulcers, 10.8% of peptic ulcers, and 5.9% of telangiectasias. By univariate analysis: packed red blood cells units transfused, transaminases, Child–Pugh (CP), model of end‐stage liver disease (MELD), and albumin–bilirubin (ALBI) scores, beside the presence of hepatocellular carcinoma (HCC), previous hemorrhage in the previous 6 months, and the source of bleeding, were associated with occurrence of complications. By multivariate analysis, independent predictors of complications were CP, MELD, and ALBI scores (odds ratio, 95% confidence interval: 5.63, 3.55–8.93; 1.15, 1.11–1.19; and 2.11, 1.4–3.19, respectively) beside the presence of HCC (4.89, 2.48–9.64). Mortality predictors were packed red blood cells units transfused (1.11, 1.01–1.24), CP (5.1, 1.42–18.25) MELD (1.27, 1.21–1.32) scores, and presence of HCC (6.62, 2.93–14.95). Conclusion High CP, MELD, and ALBI scores beside the presence of HCC could predict poor outcome of UGIB. In the absence of these risk factors, early discharge could be considered if the source of bleeding is peptic ulcer or telangiectasia.</abstract><cop>Australia</cop><pmid>30937995</pmid><doi>10.1111/jgh.14659</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-1542-0265</orcidid><orcidid>https://orcid.org/0000-0003-1286-7616</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0815-9319
ispartof Journal of gastroenterology and hepatology, 2019-09, Vol.34 (9), p.1604-1610
issn 0815-9319
1440-1746
language eng
recordid cdi_proquest_miscellaneous_2202196487
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Aged, 80 and over
ALBI score
cirrhosis
Disease Progression
Egypt - epidemiology
Esophageal and Gastric Varices - diagnosis
Esophageal and Gastric Varices - epidemiology
Esophageal and Gastric Varices - mortality
Esophageal and Gastric Varices - therapy
Female
Gastrointestinal Hemorrhage - diagnosis
Gastrointestinal Hemorrhage - epidemiology
Gastrointestinal Hemorrhage - mortality
Gastrointestinal Hemorrhage - therapy
Hemostatic Techniques
Humans
Hypertension, Portal - diagnosis
Hypertension, Portal - epidemiology
Hypertension, Portal - mortality
Hypertension, Portal - therapy
Length of Stay
Liver Cirrhosis - diagnosis
Liver Cirrhosis - epidemiology
Liver Cirrhosis - mortality
Liver Cirrhosis - therapy
Male
MELD
Middle Aged
Patient Discharge
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome
upper gastrointestinal bleeding
Young Adult
title Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A24%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upper%20gastrointestinal%20bleeding%20in%20Egyptian%20patients%20with%20cirrhosis:%20Post%E2%80%90therapeutic%20outcome%20and%20prognostic%20indicators&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=Fouad,%20Tamer%20R&rft.date=2019-09&rft.volume=34&rft.issue=9&rft.spage=1604&rft.epage=1610&rft.pages=1604-1610&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1111/jgh.14659&rft_dat=%3Cproquest_cross%3E2202196487%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2202196487&rft_id=info:pmid/30937995&rfr_iscdi=true